
CMTA Invests $200,000 to Develop Innovative Organoid Model for Charcot-Marie-Tooth Disease
GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has allocated over $200,000 to back the development of an innovative organoid model of CMT1A, the most prevalent form of this disease.
CMTA Invests $200,000 to Develop Innovative Organoid Model for Charcot-Marie-Tooth Disease Read More